Showing 8121-8130 of 8647 results for "".
- First International MIGS Data for the Omni Surgical System Presented at ESCRShttps://modernod.com/news/first-international-migs-data-for-the-omni-surgical-system-presented-at-escrs/2476893/Sight Sciences announced clinical results from the first study of the Omni Surgical System in glaucoma patients were presented at the European Society of Cataract and Refractive Surgery (ESCRS). Findings from the pilot study suggest the Omni Surgical System, which is dually indicated in
- RightEye Releases Fully Commercialized Version of EyeQ Trainer Oculomotor Exercise Programhttps://modernod.com/news/righteye-releases-fully-commercialized-version-of-eyeq-trainer-oculomotor-exercise-program/2476892/RightEye has released its fully commercialized version of EyeQ Trainer, an oculomotor exercise program. Paired with its suite of EyeQ Tests, RightEye now offers a complete solution for addressing functional vision impairments faced by millions of Americans. The product will showcase at Vis
- Nicox Provides Business Update and Upcoming Milestoneshttps://modernod.com/news/nicox-provides-business-update-and-upcoming-milestones/2476887/Nicox SA reported the financial results for Nicox and its subsidiaries for the 6 months ending June 30, 2019 and provided an update on its activities as well as key upcoming milestones. “This is a compelling and potentially transformative time for Nicox, as we make strong progress in our g
- Johnson & Johnson Vision Introduces Tecnis Synergy IOLhttps://modernod.com/news/johnson-johnson-vision-introduces-tecnis-synergy-iol/2476884/Johnson & Johnson Vision announced the availability of the Tecnis Synergy IOL for patients in Europe, Australia, and New Zealand. The Tecnis Synergy IOL creates a new standard in presbyopia-correcting IOL (PC-IOL) technology, allowing patients to experience continuous high-contrast vision fro
- Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percenthttps://modernod.com/news/bio-tissue-expands-national-footprint-ramps-up-sales-force-by-more-than-25-percent-2/2476882/Bio-Tissue, a TissueTech company, announced the expansion of its sales force to more effectively meet the needs of clinicians and their patients. “A growing body of scientific evidence has cemented CAM as a mainstay treatment for ocular surface diseases,” Grady Grant III, TissueTech Vice P
- SightGlass Vision to Present Pivotal Clinical Trial Baseline Data Evaluating Novel Lenses to Control Nearsightedness in Childrenhttps://modernod.com/news/sightglass-vision-to-present-pivotal-clinical-trial-baseline-data-evaluating-novel-lenses-to-control-nearsightedness-in-children/2476876/SightGlass Vision announced that baseline data from CYPRESS, the company’s pivotal trial assessing the safety and efficacy of novel lenses designed to control nearsightedness in children, will be presented at the 17th International Myopia Conference 2019, held
- Boost Epi-On Corneal Cross-Linking Data to Be Presented at ESCRShttps://modernod.com/news/boost-epi-on-corneal-cross-linking-data-to-be-presented-at-escrs/2476874/Avedro announced the inclusion of a wide array of Boost Epi-On cross-linking (CXL) presentations in the scientific and educational programs at the 10th EU Cornea Congress and the 37th Congress of the European Society
- Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percenthttps://modernod.com/news/bio-tissue-expands-national-footprint-ramps-up-sales-force-by-more-than-25-percent/2479535/Bio-Tissue, a subsidiary of TissueTech, announced the expansion of its sales force to more effectively meet the needs of clinicians and their patients. “A growing body of scientific evidence has cemented CAM as a mainstay treatment for ocular surface diseases,” Grady Grant III, TissueTech
- Macular Degeneration Conference Series in the Spotlighthttps://modernod.com/news/macular-degeneration-conference-series-in-the-spotlight/2476865/Part of the 2019 Macular Degeneration Association Educational Conference Series will take place on Saturday, September 21, at the Doubletree Chicago North Shore Conference Center Skokie, Illinois. The conference, “Eyes on Sight,” is aimed to deliver the most up-to-date research regarding t
- CorNeat Vision Completes Preclinical Phase For Synthetic Cornea and Scleral Patchhttps://modernod.com/news/corneat-vision-completes-preclinical-phase-for-synthetic-cornea-and-scleral-patch/2479538/CorNeat Vision announced it has completed the preclinical stage of its cornea implant (CorNeat KPro/Keratoprosthesis) and the first synthetic, non-degradable scleral patch (CorNeat EverPatch). The company’s solutions, which also include a glaucoma drainage device, the CorNeat eShunt, will b